BMS to pay up to $1.56bn for Agenus’ bispecific antibody programme
20th May 2021 Uncategorised 0BMS will pay Agenus $200m upfront and up to $1.36bn in development, regulatory and commercial milestones More: BMS to pay up to .56bn for Agenus’ bispecific antibody programme Source: News
read more